GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BB Biotech AG (GREY:BBAGF) » Definitions » Deferred Policy Acquisition Costs

BB Biotech AG (BB Biotech AG) Deferred Policy Acquisition Costs : $0.00 Mil (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is BB Biotech AG Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs represent the costs incurred by insurance companies for policy acquisitions that has not been paid.

BB Biotech AG Deferred Policy Acquisition Costs Historical Data

The historical data trend for BB Biotech AG's Deferred Policy Acquisition Costs can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BB Biotech AG Deferred Policy Acquisition Costs Chart

BB Biotech AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Deferred Policy Acquisition Costs
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

BB Biotech AG Quarterly Data
Jun16 Sep16 Dec16 Mar17 Jun17 Dec17 Dec18 Dec19 Dec20 Mar21 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Deferred Policy Acquisition Costs Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

BB Biotech AG (BB Biotech AG) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BB Biotech AG (GREY:BBAGF) » Definitions » Deferred Policy Acquisition Costs
Comparable Companies
LSE:GNS LSE:ONT LSE:PRTC LSE:BVXP LSE:OXB LSE:HVO LSE:AVCT LSE:4BB LSE:FUM LSE:FARN OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB XBRU:ARGX BNTX
Traded in Other Exchanges
BIONz:UK BBZA:Germany BION:Switzerland
Address
Schwertstrasse 6, Schaffhausen, CHE, CH-8200
Website
https://www.bbbiotech.com
BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market and is one of the largest investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system. BB Biotech follows a strategy of carefully screening and selecting biotechnology firms with a long-term time horizon and having established products in the marketplace. Geographically it earns key revenue from the Netherlands.

BB Biotech AG (BB Biotech AG) Headlines

No Headlines